Lefamulin vs Moxifloxacin for Community-Acquired Pneumonia, Caspofungin vs Fluconazole Prophylaxis in AML, GWAS Review, Treatment of Adolescent Obesity, and more
- Author
- American Medical Association
- Published
- Tue 05 Nov 2019
- Episode Link
- https://traffic.libsyn.com/secure/jamaeditorsaudiosummary/Lefamulin_vs_Moxifloxacin_for_Community-Acquired_Pneumonia_Caspofungin_vs_Fluconazole_Prophylaxis_in_AML_GWAS_Review_Treatment_of_Adolescent_Obesity_and_more.mp3
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the November 05, 2019 issue
